The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,063,468 in first-year total cost, median $3,031,734.
Most frequent study sections
- Special Emphasis Panel[ZRG1 MGG-S (70)]2
Most frequent institutions
- CHILDREN'S HOSP OF PHILADELPHIA1
- MASSACHUSETTS EYE AND EAR INFIRMARY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | AAV-mediated editing to treat human autosomal dominant hearing loss DFNA41 and DFNA21U01TR005352-01 | CHEN, ZHENG-YI | MASSACHUSETTS EYE AND EAR INFIRMARY, MA | $3,314,560 | ZRG1 |
| 2024 | Personalized prime editing as a platform for hepatic inborn errors of metabolism1U01TR005355-01 | AHRENS-NICKLAS, REBECCA CLAREMUSUNURU, KIRAN | CHILDREN'S HOSP OF PHILADELPHIA, PA | $2,748,908 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.